Birdwatch Archive

Birdwatch Note

2021-06-14 17:07:03 UTC - NOT_MISLEADING

There are conflicting studies as to whether Ivermectin is effective in COVID-19 patients. The drug is currently in multiple trials and has shown effectiveness in others. There are multiple studies showing the drug is effective and well tolerated amongst patients. https://pubmed.ncbi.nlm.nih.gov/33278625/ https://pubmed.ncbi.nlm.nih.gov/34052007/

Written by AAAF4F05B590E736347FE87B0EEB37D0
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1403777325653630976

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1404485548773883913
  • noteId - 1404485548773883913
  • participantId - AAAF4F05B590E736347FE87B0EEB37D0
  • noteAuthorParticipantId -
  • createdAtMillis - 1623690423566
  • tweetId - 1403777325653630976
  • classification - NOT_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 1
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • There are conflicting studies as to whether Ivermectin is effective in COVID-19 patients. The drug is currently in multiple trials and has shown effectiveness in others. There are multiple studies showing the drug is effective and well tolerated amongst patients. https://pubmed.ncbi.nlm.nih.gov/33278625/ https://pubmed.ncbi.nlm.nih.gov/34052007/

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2021-06-14 17:07:03 UTC
(1623690423566)		 1969-12-31 23:59:59 UTC
(-1)		 1969-12-31 23:59:59 UTC
(-1)		 1969-12-31 23:59:59 UTC
(-1)		 AAAF4F05B590E736347FE87B0EEB37D0
2021-06-14 17:07:03 UTC
(1623690423566)		 1969-12-31 23:59:59 UTC
(-1)		 1969-12-31 23:59:59 UTC
(-1)		 1969-12-31 23:59:59 UTC
(-1)		 B5571BFE8A2237CCB5CF64F792356EA51E1E62D9AD2F0CA7B047190B8C341AEF

Note Ratings

rated at rated by
2021-06-14 14:53:39 -0500 0378F20DFECC73D3AD98390D25AA66E2BCCAAB4A22DEE65AB440D4CB6446B2E7 Rating Details
2021-06-14 13:21:14 -0500 0B9FF7AEC08366A80F129E379DEADA81 Rating Details
2021-06-15 13:02:10 -0500 1E94A0AD168F6AD8BC1B1B8D6E9BE716 Rating Details
2021-10-28 08:24:29 -0500 27C2CE23A68F32F61C3B361C39E358AD Rating Details
2021-06-14 17:40:38 -0500 465A458BD93845668D8FD5F8A547068A Rating Details
2021-06-14 19:41:44 -0500 4F12EECBC9902781BE09BDEF14E2A87BFA7798BA21AE5AD18BCFAF04E71B99CA Rating Details
2021-06-14 21:06:55 -0500 58CCF5FA8496E5FA4EC51807B33E5014 Rating Details
2021-06-14 17:40:38 -0500 5FB9B68061EDA5E93528C6A547111421B76EBB9BCE4A9F6DF39B3E468E23455C Rating Details
2021-06-14 20:51:27 -0500 66641EB973CFD986EF77ECE3533060E8 Rating Details
2021-06-14 21:06:55 -0500 6EB7DF8EE94760702BBEADFFAB7094786120B09E599A6BB5DD56E03AD025B5BC Rating Details
2021-06-14 12:12:51 -0500 78A1AEE0C20993A36DC6C34EE9E0289E4E8D579F1F334B5DC3B600422DBF2D69 Rating Details
2021-07-03 08:41:11 -0500 8A2168871D9629BD97B665FCF2F3633732A7C7B6429E32AB44E607CD5ED02DC1 Rating Details
2021-06-14 20:51:27 -0500 8A2B2083E957A159F6871F31805FB1F08AB02EA9E1DAC45E369DF5C8D8C30AE5 Rating Details
2021-10-28 19:30:14 -0500 8BA54FEAC8CC0A4CA55BF6D40CDADD63 Rating Details
2021-06-15 13:02:10 -0500 8DA9031AEF948954592A85D195BED280E11F7FC86CF00BB12682C45498F4B9ED Rating Details
2021-06-14 14:38:59 -0500 99C9E6DE2BA16D23C320C1879BDDEE7DEA7686BE2B3B0C6B5AC5DD524EDA5D44 Rating Details
2021-06-16 15:55:57 -0500 A2685C8837A53848669174B756B47E3CE66CA2CEE91722DF148AF85268679908 Rating Details
2021-06-14 12:12:51 -0500 A5D341541F42A514CAB375C43499B6B7 Rating Details
2021-06-16 12:09:44 -0500 A802F982D4633E252DD45A8432C23DD74E334DC53D468C9E4EDEBD7A58AE17CB Rating Details
2021-06-14 14:53:39 -0500 A8CB5D5E5A53FEA286C15D44FBE39BF6 Rating Details
2021-06-17 09:11:57 -0500 AD7C591775C7271810A01BB363694E6B Rating Details
2021-06-17 09:11:57 -0500 AE5E0C05614C634F84F2E43FF49884B35C4F55402FF36F9F18C7763A597878B9 Rating Details
2021-06-14 14:38:59 -0500 B615F49A9CD7F18B52DAE3F567FEAA3D Rating Details
2021-10-28 08:24:29 -0500 B9EA54680B5F3D6538FD4EC49D92D3A749677AC19D5DF3A7BDEA26D2D4DA31D1 Rating Details
2021-06-16 12:09:44 -0500 CD323EF47891ED501D928260874E9915 Rating Details
2021-07-03 08:41:11 -0500 D04A292AB1E001D73365D859586A36C8 Rating Details
2021-06-14 19:41:44 -0500 D318D3A96570F4DC9E974271180FF4A0 Rating Details
2021-06-16 15:55:57 -0500 DA256269170B40C6C4F3500C6E501467 Rating Details
2021-06-14 13:21:14 -0500 F51952BD324C1E1289712144ED61CA708D5DB2055C282D5573CD23B0CE1C27BF Rating Details
2021-10-28 19:30:14 -0500 FA8BB8940D572D0A56637BF69AC266B85516619E6425B10D8662F91551479266 Rating Details
2021-06-14 17:40:38 -0500 Rating Details
2021-06-14 20:28:03 -0500 Rating Details
2021-06-14 20:28:03 -0500 Rating Details
2021-06-17 09:11:57 -0500 Rating Details
2021-06-14 13:21:14 -0500 Rating Details
2021-06-14 19:41:44 -0500 Rating Details
2021-06-15 13:02:10 -0500 Rating Details
2021-06-16 12:09:44 -0500 Rating Details
2021-10-28 19:30:14 -0500 Rating Details
2021-07-03 08:41:11 -0500 Rating Details
2021-06-14 20:51:27 -0500 Rating Details
2021-06-14 12:12:51 -0500 Rating Details
2021-06-16 15:55:57 -0500 Rating Details
2021-06-14 14:53:39 -0500 Rating Details
2021-06-14 21:06:55 -0500 Rating Details
2021-10-28 08:24:29 -0500 Rating Details
2021-06-14 14:38:59 -0500 Rating Details